Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Day One Biopharmaceuticals Inc

DAWN
Current price
13.31 USD -1.04 USD (-7.25%)
Last closed 14.32 USD
ISIN US23954D1090
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 1 652 865 920 USD
Yield for 12 month +13.57 %
1Y
3Y
5Y
10Y
15Y
DAWN
21.11.2021 - 28.11.2021

Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genomically defined cancers. Its lead product candidate is tovorafenib, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric patients with relapsed/ refractory low-grade glioma. The company is also developing Pimasertib, an oral small molecule inhibitor of mitogen-activated protein kinase kinases 1 and 2. Day One Biopharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Brisbane, California. Address: 2000 Sierra Point Parkway, Brisbane, CA, United States, 94005

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

37 USD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

+20 070 000 USD

Last Quarter

+8 192 000 USD

Current Year

-383 000 USD

Last Year

-531 000 USD

Current Quarter

+18 480 000 USD

Last Quarter

+7 485 000 USD

Key Figures DAWN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -205 504 000 USD
Operating Margin TTM 31.61 %
PE Ratio
Return On Assets TTM -25.43 %
PEG Ratio
Return On Equity TTM -17.84 %
Wall Street Target Price 37 USD
Revenue TTM 101 953 000 USD
Book Value 5.51 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -0.97 USD
Diluted Eps TTM -0.97 USD
Most Recent Quarter III 2024
Quarterly Earnings Growth YOY
Profit Margin -82.68 %

Dividend Analytics DAWN

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History DAWN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation DAWN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 10.7609
Price Sales TTM 16.212
Enterprise Value EBITDA -7.1769
Price Book MRQ 2.9757

Financials DAWN

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators DAWN

For 52 weeks

11.3 USD 18.07 USD
50 Day MA 14.34 USD
Shares Short Prior Month 15 667 396
200 Day MA 14.65 USD
Short Ratio 15.49
Shares Short 15 976 358
Short Percent 19.15 %